Market Overview

Benzinga's Top Upgrades

Share:
Related CAH
Benzinga's Top Downgrades
Analyst: Cardinal Health Buying Spree To Boost FY17 EPS
Should You Buy Evolving Trends in Medical Devices? - Industry Outlook (Zacks)
Related LLY
Lilly Issues Update on Evacetrapib Phase 3 Trial: Last Patient Visit in ACCELERATE Expecting Jul. '16
Analyst's Key Takeaways From Eli Lilly, Bristol-Myer Squibb's Latest Conference Calls
Seeking Alpha's Biotech Weekly: The Mystery Of Gilead Sciences (Seeking Alpha)

Analysts at ISI Group upgraded Cardinal Health (NYSE: CAH) from “hold” to “buy.” Cardinal Health's shares closed at $40.85 yesterday. Cardinal Health's trailing-twelve-month ROE is 17.70%.

Analysts at Goldman Sachs upgraded Eli Lilly & Co (NYSE: LLY) from “sell” to “neutral.” Eli Lilly's shares closed at $50.78 yesterday. Eli Lilly's trailing-twelve-month revenue is $23.40 billion.

Analysts at Citigroup upgraded The Interpublic Group of Companies (NYSE: IPG) from “neutral” to “buy.” Interpublic Group's stock closed at $11.43 yesterday. Interpublic Group's PEG ratio is 1.16.

Analysts at Sterne Agee upgraded Shoe Carnival (NASDAQ: SCVL) from “neutral” to “buy.” Shoe Carnival's shares closed at $22.65 yesterday. Shoe Carnival's trailing-twelve-month operating margin is 5.61%.

Latest Ratings for CAH

DateFirmActionFromTo
Jul 2015Evercore ISIDowngradesBuyHold
Jun 2015Deutsche BankMaintainsHold
Mar 2015FBR CapitalMaintainsOutperform

View More Analyst Ratings for CAH
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CAH + IPG)

Get Benzinga's Newsletters